Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Stimulation Intervention Program for Cancer Survivors and Its Benefit on Cognitive Performance and Quality of Life

NCT05409248 is registered in ClinicalTrials.gov with Universidad Antonio de Nebrija as lead sponsor.

NCT NCT05409248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Stimulation Intervention Program for Cancer Survivors and Its Benefit on Cognitive Performance and Quality of Life
Lead sponsor
Universidad Antonio de Nebrija
Phase
Not applicable
Overall status
Unknown status
Start date
June 3, 2022
Completion date
December 31, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cognitive decline